Product Description

The U.S. neurological device market was valued at over $7.6 billion in 2024. This is expected to increase over the forecast period at a CAGR of 3.8% to reach nearly $10 billion.

The full report suite on the U.S. market for neurological devices includes the cerebrospinal fluid management, detachable coil, liquid embolic, neurovascular catheter, neurovascular guidewire, neurovascular stent, balloon occlusion device, aneurysm clip, neurovascular thrombus management, neuromodulation device, intrathecal pump, stereotactic device, neuroendoscopy and ultrasonic aspirator markets.

Advancements in neurological devices are rapidly evolving, driven by innovations in neuromodulation, brain-computer interfaces (BCIs) and artificial intelligence (AI)-powered diagnostics. Closed-loop neuromodulation systems now offer real-time, patient-specific adjustments for conditions like Parkinson’s disease and epilepsy, enhancing therapeutic efficacy. In stroke care, next-generation thrombectomy devices integrate advanced aspiration and stent retrievers for faster and more effective clot removal. Meanwhile, BCIs are breaking new ground in restoring motor function for paralyzed patients by translating neural activity into digital commands. AI and machine learning are also revolutionizing neurological diagnostics, improving early detection of neurodegenerative diseases through predictive imaging and biomarker analysis. These breakthroughs are reshaping patient care, offering more personalized, efficient and minimally invasive treatment options.

MARKET REPORT DATA TYPES INCLUDED

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Procedure Numbers
• Market Drivers & Limiters
• Market Forecasts Until 2031, and Historical Data to 2021
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitors

U.S. NEUROLOGICAL DEVICE MARKET INSIGHTS 

Neuromodulation remains the dominant segment in the neurological device market, driven by continuous advancements in spinal cord stimulation, deep brain stimulation and emerging technologies in closed-loop and adaptive stimulation. The increasing adoption of minimally invasive neuromodulation techniques, coupled with expanding indications in pain management, movement disorders and even psychiatric conditions, is fueling market expansion. Meanwhile, neurovascular thrombectomy is experiencing significant growth as advancements in aspiration catheter technology enhance procedural efficiency and patient outcomes. The market is witnessing intensified competition among established players and newer entrants who are leveraging artificial intelligence and real-time imaging integration to optimize clot retrieval. With growing awareness and improving stroke center accessibility, thrombectomy procedure volumes are set to rise, addressing a critical gap in acute stroke treatment.

U.S. NEUROLOGICAL DEVICE MARKET SHARE INSIGHTS

• Medtronic remains a dominant player in the neurological device market, but increasing competition has eroded several of its historical monopolies. While the company continues to hold exclusive control in the gastric electric stimulation market, new competitors are advancing through the U.S. Food and Drug Administration (FDA) approval process. In the liquid embolic, intrathecal pump and stereotactic device markets, Medtronic continues to command more than half of the market share. However, the neuromodulation sector is becoming increasingly competitive, particularly with Axonics introducing new products in the sacral nerve stimulation segment. Despite these challenges, Medtronic continues to innovate, leveraging its extensive research and development capabilities to maintain its leadership and expand its portfolio in advanced neurological solutions. In January 2025, Medtronic achieves Conformité Européenne (CE) mark approval for BrainSense Adaptive deep brain stimulation and Electrode Identifier, a groundbreaking advance in personalized, sensing-enabled care for people with Parkinson’s through innovative BCI technology.
• Stryker ranked as the second-largest competitor in the global neurological device market, primarily due to its strong performance in the neurovascular guidewire, detachable coil and ultrasonic aspirator sectors. In January 2025, Stryker said it has a definitive agreement to purchase Inari Medical. Stryker characterized Inari’s product portfolio for venous thromboembolism as innovative and highly complementary to Stryker’s neurovascular business. Stryker has also expanded its portfolio by focusing on innovative neurological solutions, including advancements in minimally invasive procedures, positioning itself as a key player in the evolving field of neurological devices.
• Abbott emerged as the third-leading competitor in the neurological device market, thanks to its significant share in the space. Further strengthening its portfolio, Abbott gained FDA approval in 2020 for an extended indication for its Infinity™ Deep Brain Stimulation system and the directional lead, specifically targeting Parkinson’s disease. In January 2025, Abbott announces that its BurstDR™ spinal cord stimulation (SCS) technology has shown long-term efficacy in providing sustained relief for people with chronic back and leg pain, according to four-year data shared at the 2025 North American Neuromodulation Annual Meeting. The therapy, which uses pulses of mild electrical energy without causing the tingling sensation common in traditional treatments, has improved pain, sleep and daily function for patients, with 91% preferring it over traditional methods. Abbott also introduced the NeuroSphere™ Digital Health app, expanding its connected care ecosystem to support patients throughout their treatment journey.

MARKET SEGMENTATION SUMMARY

• Cerebrospinal Fluid (CSF) Market – Further Segmented Into:
  • Device Type: CSF Shunt and CSF External Drainage System.
• Detachable Coil Market – Further Segmented Into:
  • Material Type: Bare Platinum and Coated.
• Liquid Embolic Market
• Neurovascular Catheter Market – Further Segmented Into:
  • Device Type: Over-the-Wire Microcatheter, Flow-Directed Microcatheter and Neurovascular Guiding Catheter.
• Neurovascular Guidewire Market
• Neurovascular Stent Market – Further Segmented Into:
  • Device Type: Traditional Neurovascular, Flow Diversion Stent, and Intrasaccular Stent.
• Balloon Occlusion Device Market
• Aneurysm Clip Market – Further Segmented Into:
  • Material Type: Titanium and Cobalt Alloy.
• Neurovascular Thrombus Management Market – Further Segmented Into:
  • Device Type: Stent Receiver, Aspiration Catheter. and Aspiration Pump Canister.
• Neuromodulation Device Market – Further Segmented Into:
  • Device Type: Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electric Stimulation, Dorsal Root Ganglion Stimulation, and Responsive Neurostimulation Device.
• Intrathecal Pump Market
• Stereotactic Device Market – Further Segmented Into:
  • Device Type: Frame-based and Frameless.
• Neuroendoscopy Market – Further Segmented Into:
  • Device Type: Rigid Endoscope, Flexible Endoscope, Videoscope, Single-Use Endoscope, Neuroendoscopic Hand Instrument, and Neuroendoscopy Disposables.
• Ultrasonic Aspirator Market – Further Segmented Into:
  • Device Type: Capital Equipment, Disposable Probe Tip, Disposable Tubing, Handpiece, and Accessories.

 RESEARCH SCOPE SUMMARY

CONTACT US FOR ADDITIONAL INFORMATION

For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.

FREE Sample Report